The transcription factor NF-B plays an important role in the regulated expression of cytokines in human monocytes. A p100 subunit of NF-B has IB-like properties by sequestering the p65 transactivating subunit in the cytosol of cells. In transient transfection assays we demonstrated that p100 has an inhibitory effect on the NF-B-dependent IL-6 promoter activity. In view of this finding, we studied the regulation of the p100 subunit in human monocytes in response to LPS, the inflammatory cytokines IL-1␤ and TNF-␣ and lymphokines. The results demonstrate that LPS, IL-1␤, and TNF-␣ induce p100 expression at mRNA and protein level while IFN-␥, IL-3 and IL-4/IL-10 have no effect. The induction of p100 expression was shown to be mediated by a two-fold increase in the p100 transcription rate and a two-fold increase in p100 mRNA stability. Furthermore the p100 mediated upregulation was dependent on a tyrosine kinase dependent pathway rather than the protein kinase C pathway. NF-B is a complex of either p50 homodimers or a p50/p65 heterodimer. The latter is known to strongly autoregulate p100 transcription. We therefore examined the composition of NF-B induced by LPS vs the different lymphokines. LPSinduced NF-B showed a distinct p65 supershift whereas the composition of NF-B induced by different lymphokines did not show a change in p65. We conclude that the p100 subunit of the transcription factor NF-B is induced by different inflammatory mediators while lymphokines fail to induce p100 expression which may be caused by the induction of NF-B predominantly consisting of p50 homodimers.
Introduction
The transcription factor nuclear factor-B (NF-B) is involved in the transcriptional regulation of several cytokine genes. More specific, the transcriptional regulation of genes encoding for interleukin-1 (IL-1), IL-6, IL-8, and granulocyte-colony stimulating factor (G-CSF) in human monocytes strongly depend on the activation of NF-B. [1] [2] [3] [4] [5] [6] [7] This underscores the importance of this transcription factor in hematopoiesis and inflammation. NF-B is composed of different subunits bound to an inhibitor protein (IB) which dissociates upon activation finally leading to the nuclear translocation of NF-B. [8] [9] [10] The subunits of NF-B are encoded by the genes NFKB1 (p105), NFKB2 (p100), RelA (p65), RelB and c-rel. [11] [12] [13] [14] [15] [16] [17] [18] Recently it has been shown in T cell lines that p100 has a strong IB-like activity by sequestering the RelA subunit of NF-B in the cytosol of cells. 19 Transfection experiments with expression vectors for RelA and p100 confirmed these results by demonstrating that p100 inhibited the RelA-mediated transcriptional activity of reporter genes. 20, 21 In view of these data it is conceivable that IB and p100 might have important functions in negative control mechanisms.
Limited information is available regarding how the p100
Correspondence: E Vellenga, Department of Internal Medicine, Division of Hematology, University Hospital, Hanzeplein 1, 9713 GZ Groningen, The Netherlands; Fax: 31 50 3614862 Received 11 June 1997; accepted 11 November 1997 expression in human monocytes is regulated and how this correlates with the well defined effects of up-and down-regulation of cytokine gene expression in monocytes. To study these aspects in more detail, we analyzed the regulation of p100 in response to lipopolysaccharide (LPS) and different cytokines. Transient transfection assays demonstrated that a p100 expression vector inhibits NF-B-driven IL-6 promoter activity. In addition it was shown that p100 in monocytes is regulated at transcriptional and post-transcriptional levels in response to LPS, IL-1 and TNF. In contrast, IL-3, IL-4/IL-10 and IFN-␥ failed to induce p100 expression.
Materials and methods

Cell culture and isolation of monocytes
Peripheral blood cells were obtained from volunteer platelet donors, and mononuclear cell suspensions were prepared by Ficoll-Hypaque density-gradient centrifugation. T lymphocytes were removed by E-rosetting with 2-aminoethyl-isothiouronium-bromide-treated sheep red blood cells. Monocytes were further enriched by plastic adherence for 1 h at 37°C and demonstrated a purity Ͼ95% detected by FACS analysis with an anti-CD-14 monoclonal antibody (Becton Dickinson, Sunnyville, CA, USA) and staining. Monocytes were cultured in RPMI-1640 medium containing 10% FBS and antibiotics. TF-1 cells were cultured in RPMI-1640 medium (Flow, Rockville, MD, USA) containing 10-ng/ml IL-3 (Genetics Institute, Cambridge, MA, USA), 10% fetal bovine serum (FBS; Hyclone, Logan, UT, USA) and antibiotics.
Monocytes were stimulated with 1 g/ml lipopolysaccharide (LPS) from Pseudomonas aeruginosa (Sigma, St Louis, MO, USA), interferon-␥ (100 U/ml; Boehringer Mannheim, Mannheim, Germany), tumor necrosis factor-␣ (500 U/ml; a gift from Dr GR Adolf, Ernst, Boehringer Ingelheim, Vienna, Austria), IL-1␤ (100 U/ml; Immunex; Seattle, WA, USA), IL-3 (10 ng/ml; Genetics Institute, Cambridge, MA, USA), IL-4 (15 ng/ml; a gift from Dr P Trotta, Schering-Plough, Bloomfield, NJ, USA), IL-10 (5 ng/ml; Schering-Plough, Kenilworth, NJ, USA). Polyclonal anti-serum against IL-1␣, IL-1␤ (gifts from Dr S Gillis, Immunex, Seattle, WA, USA), and TNF-␣ (a gift from Dr GR Adolf) was used at a dilution of 1:1000. These dilutions completely neutralize the activity of IL-1 (200 U/ml) and TNF (200 U/ml) tested in in vitro culture assays. Okadaic acid (Sigma), cycloheximide (Sigma), actinomycin-D (Boehringer Mannheim), genistein (Sigma), chelerithrin (Sigma) and staurosporin (Sigma) were used at concentrations of 30 ng/ml, 10 g/ml, 10 g/ml, 40 M, 1 M and 20 mM, respectively. The viability of monocytes after stimulation was Ͼ99% in all experiments.
Expression plasmids and transfection procedures
A p100 expression vector was constructed by cloning a 2.9 kb HindIII-XbaI p100 cDNA (a gift from Dr G Nabel, Ann Arbor, MI, USA) containing the entire p100 coding sequence into pcDNA3 (InVitroGen, San Diego, CA, USA). An IB expression vector was kindly provided by Dr A Baldwin (Chapel Hill, NC, USA). An NF-B-driven IL-6 promoter luciferase reporter plasmid was a gift from Dr S Akira (Osaka, Japan).
TF-1 cells were co-transfected with the NF-B driven luciferase reporter plasmid in the absence and presence of pcDNA3, a p100 expression vector, and an IB expression vector. Transfection was performed by electroporation at 240 V and 960 F and subsequently cells were cultured in RPMI-1640 medium plus 10% FBS in the absence or presence of Okadaic acid or IL-1. After 24 h luciferase activity in cell extracts was measured using a luminometer.
RNA preparation and Northern blot analysis
Total cellular RNA was isolated using the guanidium isothiocyanate/cesium chloride method. Fifteen microgram samples of total cellular RNA were size fractionated on 1.1% agarose gels with 2.2 M formaldehyde and blotted onto nylon membranes (Hybond N+; Amersham, Bucks, UK). A HindIII/XbaI excised p100 cDNA probe (a gift of Dr G Nabel) was labeled with 32 P dCTP (3000 Ci/mmol; Amersham) using the hexanucleotide primer technique. 22 Hybridization was performed at 65°C for 18 h in 0.5 M Na 2 HPO 4 , pH 7.2, 1 mM EDTA, 7% SDS. Membranes were washed in 2 × SSC, 0.1% SDS (65°C, 30 min), 1 × SSC, 0.1% SDS (65°C, 30 min) and finally in 0.3 × SSC, 0.1% SDS (65°C, 30 min). Membranes were then exposed to X-ray films (Kodak X-Omat XAR) at −80°C using an intensifying screen. Quantification of mRNA levels was performed by densitometry using a gel scan laser densitometer (Pharmacia LKB, Uppsala, Sweden).
Figure 1
Transfection experiments in TF-1 cells with an NF-Bdriven IL-6 promoter luciferase reporter plasmid co-transfected with either a pcDNA3 plasmid, a p100 expression vector or an IB expression vector. Transfected cells were stimulated with medium or with Okadaic acid (30 ng/ml) and after 24 h luciferase activity was determined. The histogram shows the relative luciferase activity presented as the mean and s.d. from four independent transfection experiments.
Run on transcription assay
The transcription rate of the NFKB2 gene was studied as described previously. 23 In short, nuclei of 5 × 10 7 cells were isolated and resuspended in transcription buffer containing 32 P-UTP (3000 Ci/mmol; Amersham) and incubated at 26°C for 20 min. Transcription was terminated and nuclear RNA was isolated and hybridized to linearized pGEM and to linearized plasmids containing the cDNA inserts for the p100, IL-1 and GAPDH genes. Hybridization, washing, exposure and quantification of transcription rates was performed as described above.
Electrophoretic mobility shift assay (EMSA)
Monocytes were stimulated and nuclear extracts were prepared according to the mini-scale procedure as described. 23, 24 Nuclear extracts were divided in small aliquots and stored at −80°C.
A double-stranded synthetic oligonucleotide probe containing the NF-B (5′-AGCTGCGGGGATTTTCCCTG-3′) was used in a gel retardation assay. Fifty nanograms of HPLC-purified single-stranded oligonucleotide were labeled with T4-polynucleotide kinase and ␥ 32 P ATP (3000 Ci/mmol; Amersham), separated from non-incorporated radiolabel by sephadex G50 chromatography, ethanol precipitated, dried, and dissolved in 20 l of 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 10 mM MgCl 2 , 1 mM EDTA and 1 mM DTT, containing a fourfold excess of the opposite strand. Annealing of the two strands was performed by heating the mixture for 2 min at 90°C and slow cooling to room temperature.
Ten micrograms of nuclear extract and 0.1 ng doublestranded labeled oligonucleotide were incubated in 20 mM HEPS (pH 7.9), 60 mM KCl, 0.06 mM EDTA, 0.6 mM DTT, 2 mM spermidine, 10% glycerol, supplemented with 2 g poly(dI-dC). The binding reaction was performed at 26°C for 25 min. Supershift experiments were performed by incubating the nuclear extracts with polyclonal antibodies against p50, p52 and p65 subunits of NF-B (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The specificity of NF-B DNA-binding was tested by competition experiments using a 100-fold excess of unlabeled self and non-self oligonucleotide. The samples were loaded on pre-run (30 min, 100 V) 4% (30:1) polyacrylamide gels and run for 1 h at 150 V in 0.5 × TBE at room temperature. Gels were dried and exposed to Kodak XAR films (Rochester, NY, USA) at −80°C with an intensifying screen.
Western blot analysis
Monocytes were stimulated and equal amounts of cytosol extracts were electrophoresed on SDS-polyacrylamide gels and transferred to nitrocellulose membranes. Cytosol extracts were prepared according to the miniscale procedure. 24 Blots were stained with Ponceau S to control protein loading in each lane. Immunoreactive proteins were detected using the ECL chemiluminescent detection system (Amersham) and a p52 rabbit polyclonal antibody (Santa Cruz Biotechnology). Shown are the p100 proteins (Figures 2 and 5) . The p52 protein could not be demonstrated in cytosol extracts.
Statistical analysis
Statistical analysis was performed using the Student's t-test for paired observations.
Results
NF-B-dependent IL-6 promoter activity is inhibited by p100
TF-1 cells were co-transfected with an NF-B driven IL-6 promoter luciferase reporter plasmid in conjunction with an empty expression vector (pcDNA3), a p100 expression vector, or an IB expression vector. After transfection, cells were stimulated with medium (control) or Okadaic acid(30 ng/ml) which is known to be a strong inducer of IL-6 mRNA and NF-B activity in monocytic cells. 25 As shown in Figure 1 , Okadaic acid strongly induces the NF-B-induced luciferase activity in TF-1 cells. Cells co-transfected with a p100 expression vector show a significantly decreased luciferase activity (100% vs 24.2% ± 6.4%; X ± s.d., n = 4; P Ͻ 0.01) which was comparable to inhibitory effects of co-transfection with an IB expression vector (100% vs 23.1% ± 6.9%; X ± s.d., n = 4; P Ͻ 0.01). Moreover, co-transfection with both p100 and IB expression vectors seemed to have an additive inhibitory effect on the NF-B-dependent IL-6 promoter activity compared to p100 and IB alone (9.7% ± 3.0% vs 24 .2% and 23.1%, respectively; X ± s.d., n = 4; P Ͻ 0.05). Similar results were observed after stimulation with IL-1 (data not shown). This demonstrates that p100 had an IB-like activity and is able to inhibit NF-B-dependent IL-6 promoter activity. In view of these results we focused on regulation of p100 expression in monocytes.
Figure 2
Kinetics of LPS-induced p100. Monocytes were treated with LPS (1 g/ml) for the indicated periods of time. Northern (a) and Western blotting (b) were used to detect p100 mRNA and protein, respectively. The experiment shown is representative of three experiments performed.
LPS-induced p100 expression in human monocytes
To study the regulation of p100 expression in monocytes, cells were stimulated with LPS (1 g/ml) and at different points of time total cellular RNA was isolated and analyzed for the expression of NF-B p100 mRNA. Unstimulated cells show a basal expression of p100 mRNA which could be strongly induced by LPS stimulation (Figure 2a) . Optimal p100 mRNA expression was noticed after 3 hours of stimulation with LPS. Comparable results were obtained at protein level as depicted in Figure 2b .
Figure 3
Effects of protein synthesis inhibition and inhibition of second messenger pathways on the LPS-induced p100 mRNA expression. (a) Monocytes were treated with medium (control), cycloheximide (CHX; 10 g/ml) for 3 h, LPS (1 g/ml) for 3 h, and pretreated with cycloheximide for 30 min followed by LPS stimulation for 3 h. (b) Monocytes were treated with medium (control), LPS (1 g/ml) for 3 h and pre-treated with genistein (40 M) and staurosporin (20 mM) followed by LPS for 3 h. Total cellular RNA was analyzed for p100 mRNA expression by Northern blotting. Hybridization with a 28S probe was assessed to control RNA loading in each lane. Quantification of mRNA levels was performed by densitometric scanning. The experiments shown are representative of two independent experiments.
Signalling pathways involved in the p100 regulation
To study whether the LPS-induced p100 mRNA expression was dependent on protein synthesis, monocytes were pretreated with cycloheximide (10 g/ml) for 30 min followed by stimulation with LPS (1 g/ml) for 3 h. Figure 3a demonstrates Figure 4 (a) Nuclear run on experiment to determine the p100 transcription rate in response to LPS. Monocytes were treated with medium (control) and with LPS (1 g/ml) for 3 h. After transcription was blocked, RNA was isolated and hybridized to plasmids containing no insert (pGEM), p100, IL-1, and GAPDH cDNA inserts. Relative mRNA levels were determined by densitometric scanning and normalization of the signal to the respective GAPDH signals. (b) Experiments to determine the half-life of p100 mRNA. Monocytes were treated with medium (control) and with LPS (1 g/ml) for 3 h. Actinomycin-D (10 g/ml) was added to inhibit transcription. At various time points after the addition of actinomycin-D p100 mRNA was detected by Northern blotting. The graphic analysis of p100 mRNA half-life was determined by densitometric scanning and normalization to 28S signals. The experiments shown are representative of two independent experiments. superinduction of p100 mRNA in response to cycloheximide stimulation. LPS treatment in the presence of cycloheximide further induced p100 mRNA, indicating that p100 induction is independent of protein synthesis. Next, we studied the role of the protein kinase C (PKC) and the tyrosine kinase-dependent second messenger pathways. Monocytes were pre-treated with staurosporin (20 mM) and with genistein (40 M) for 30 min to inhibit the PKC and tyrosine kinase-dependent pathway, respectively, followed by LPS stimulation for 3 h (Figure 3b ). Staurosporin and chelerithrin (data not shown) failed to inhibit the LPS-induced p100 mRNA expression although the PKC-dependent pathway was effectively blocked since the LPS-induced IL-1 mRNA expression could be inhibited (data not shown). In contrast, a reduced LPS-dependent p100 mRNA expression (65%) was noticed in monocytes that were pretreated with genistein. This suggests a role for the tyrosine kinase-dependent signaling pathway in the LPSinduced p100 expression while the PKC pathway seems not to be involved.
Next nuclear run on experiments were performed to study the p100 transcription rate. Figure 4a shows a representative experiment with a basal transcription of the p100 gene in unstimulated monocytes. Stimulation with LPS for 3 h resulted in a two-fold increase in the transcription rate of the p100 gene. Potential regulation of stability of p100 mRNA was studied by inhibiting transcription with actinomycin-D after cell stimulation. The half-life of p100 mRNA of unstimulated monocytes was approximately 60 min ( Figure 4b ). Stimulation with LPS resulted in half-life of approximately 120 min. We conclude that LPS induces p100 expression in monocytes by increasing the p100 transcription rate and p100 mRNA stability.
Modulatory effects of lymphokines and inflammatory cytokines on the p100 expression IL-1 and TNF are both strong inducers of an inflammatory reponse that is proceeded by a transient induction of NF-B binding activity. 3, 26, 27 To study the effects on p100 mRNA expression, monocytes were stimulated with TNF-␣ (500 U/ml) and IL-1␤ (100 U/ml) at different points of time. The results presented in Figures 5a and 6a show a time-dependent increase of p100 mRNA expression with optimal expression at 1 h and 3 h of stimulation respectively. Comparable results were obtained at protein level (Figure 5c ). Next we excluded the possibility that the LPS-mediated effects are related to the release of IL-1 and TNF since anti-TNF and anti-IL-1 did not suppress the LPS-mediated p100 upregulation. In contrast, stimulation with IFN-␥ (100 U/ml), IL-3 (10 ng/ml),
Figure 6
Effects of IL-1␤ on p100 mRNA expression. Monocytes were treated with IL-1␤ (100 U/ml) for the indicated periods of time (a) and treatment with anti-IL-1 was assessed to control the specificity of LPS-induced p100 mRNA (b). Northern blotting was used to detect p100 mRNA levels. The experiments shown are representative of two independent experiments. and IL-4 (15 ng/ml)/IL-10 (5 ng/ml) did not change the p100 mRNA levels (Figure 7) . Similarly, priming of monocytes with these cytokines followed by LPS stimulation did not affect p100 mRNA expression.
Next we questioned whether a difference in NF-B composition might be related to the diversity in effects since all the activators are capable of inducing NF-B DNA binding activity. 28 Supershift experiments were performed using antibodies against the p50 and p65 subunits of NF-B. 
Discussion
The expression of cytokines such as IL-1, IL-6, TNF, and other inflammatory mediators by human monocytes strongly depends on the activation of the transcription factor NF-B. Feedback mechanisms are necessary to limit the cytokine production and thus control the inflammatory response. A feasible negative regulator of the transcription factor NK-B might be the p100 subunit which is able to sequester the transactivating p65 subunit in the cytosol of cells.
In the present study we analyzed the function and regulation of the p100 subunit of the transcription factor NF-B especially in human monocytes. First it was shown by transient transfection experiments that p100 is able to inhibit the NF-B-dependent IL-6 promoter activity. In these experiments the degree of suppression was comparable to the inhibition induced by IB. Moreover, co-transfection of both expression vectors resulted in a further inhibition suggesting a specific function of either protein.
In monocytes p100 is selectively induced, in a protein-independent way, by LPS, IL-1 and TNF but not by the lymphokines IFN-␥, IL-3 and IL-4/IL-10. Both transcriptional and posttranscriptional mechanisms control expression of p100, in part regulated by tyrosine kinase second messenger pathways. Apart from the involvement of protein tyrosine kinase pathways, Shapira et al 29 demonstrated the involvement of a PKCdependent pathway in monocytes. However, a PKC-dependent pathway seems not to be involved in the control of p100 mRNA expression since staurosporin and chelerythrin chloride failed to have an inhibitory effect.
Studies with reporter assays in which p100 promoter deletions were used have shown that different B-binding sites are important in the regulation of the gene. 30 In view of these data it would be expected that all cytokines which are capable of inducing NF-B would upregulate the expression of the p100 gene. However, the results demonstrate that IFN-␥ and IL-3 did not modulate p100 mRNA expression although they did induce NF-B. The discrepancy between the effects of IFN-␥ and IL-3 vs LPS, IL-1 and TNF might be related to the fact that the composition of NF-B was different. In supershift experiments we demonstrated that LPS induced a distinct p65 supershift while the p65 supershift in extracts of monocytes stimulated with IFN-␥ and IL-3 was similar to that in unstimulated cells. These data suggest that the LPS-induced NF-B consists of p65/p50 heterodimer whereas IFN-␥ and IL-3 induce p50 homodimers. These results are in line with data obtained by Sun et al 19 demonstrating that p65 markedly induced p100 protein while no effect was observed of p50.
Finally the results demonstrate that activation of NF-B is associated with the induction of proteins that act as repressors. Interestingly, IB and p100 induction follow different time kinetics. IB protein is induced within 30 min after stimulation whereas p100 protein expression is optimal after 3 h of stimulation, 9 which is preceded by a decline in IL-1 and IL-6 mRNA expression. 31 Optimal expression of IL-1, G-CSF and IL-6 mRNA in monocytes is observed after 1-2 h of activation. 32 It is still unknown what the relative roles for both repressors are in feedback mechanisms of NF-B activity. However, it might be speculated that the degree and type of repression depends on the second messenger pathway that is triggered. In this regard it is of interest to note the difference in binding; IB binds to p50/p65 heterodimers whereas p100 binds the p65 subunit. 19, 33 Further studies are needed to elucidate the complex interactions and feedback mechanisms that control NF-B-mediated responses.
Figure 7
Effects of lymphokines on the p100 mRNA expression. Monocytes were treated with medium (control), LPS (1 g/ml) for 3 h, and with the lymphokines IFN-␥ (100 U/ml), IL-3 (10 ng/ml), and IL-4 (15 ng/ml)/IL-10 (5 ng/ml) for 6 h. Furthermore, monocytes were primed with the different lymphokines for 3 h followed by LPS stimulation for 2 h. Northern blotting was used to determine p100 mRNA levels. The experiments shown are representative of three independent experiments.
Figure 8
Analysis of the composition of the NF-B complex in response to LPS and lymphokines. Monocytes were stimulated with medium (control), LPS (1 g/ml), IFN-␥ (100 U/ml), IL-3 (10 ng/ml), and with IL-4 (15 ng/ml)/IL-10 (5 ng/ml) for 2 h. Nuclear extracts were used in a supershift experiment with antibodies against the p50 and the p65 subunits of NF-B.
